Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019

Biologicals, vol. 66, pp. 53–61

Authors 22

1. Isabelle Bekeredjian‐Ding

   University of Bonn · University Hospital Bonn · Paul Ehrlich Institut

   Affiliation as printed

   Paul-Ehrlich-Institut (PEI), Langen, Germany; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany. Electronic address: Isabelle.Bekeredjian-Ding@pei.de

   Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany

   Paul-Ehrlich-Institut (PEI), Langen, Germany

2. Wim Van Molle

   Sciensano (Belgium)

   Affiliation as printed

   Sciensano, Brussels, Belgium. Electronic address: Wim.VanMolle@sciensano.be

   Sciensano, Brussels, Belgium

3. Marc F.D. Baay

   KU Leuven

   Affiliation as printed

   P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com

   P95 Epidemiology & Pharmacovigilance, Leuven, Belgium

4. Pieter Neels corresponding

   International Alliance for Biological Standardization

   Affiliation as printed

   International Alliance for Biological Standardization (IABS), Belgium. Electronic address: pieter.neels@vaccine-advice.be

   International Alliance for Biological Standardization (IABS), Belgium

5. Nele Berthels
   Affiliation as printed

   Federal Agency for Medicines and Health Products (FAMHP), Belgium

6. Christoph Conrad

   Paul Ehrlich Institut

   Affiliation as printed

   Paul-Ehrlich-Institut (PEI), Langen, Germany

7. Angela van Diepen Aachen Department of Parasitology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Parasitology, Leiden University Medical Center, the Netherlands

8. Sarah M. Fortune

   Harvard University

   Affiliation as printed

   Harvard T.H. Chan School of Public Health, Boston, United States

9. Karen Goetz

   Paul Ehrlich Institut

   Affiliation as printed

   Paul-Ehrlich-Institut (PEI), Langen, Germany

10. Andrew R. GORRINGE

    Public Health England

    Affiliation as printed

    Public Health England, Porton Down, United Kingdom

11. Daniel Fredric Hoft

    Saint Louis University

    Affiliation as printed

    Center for Vaccine Development, Saint Louis University, MO, United States

12. Robert C. Johnson

    Biomedical Advanced Research and Development Authority · Administration for Strategic Preparedness and Response

    Affiliation as printed

    Influenza and Emerging Infectious Diseases Division, Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), United States

13. Peter G. Kremsner

    University of Tübingen

    Affiliation as printed

    Institute of Tropical Medicine, University of Tübingen, Germany

14. Oleg Krut

    Paul Ehrlich Institut

    Affiliation as printed

    Section Microbiological Safety, Paul-Ehrlich-Institut, Langen, Germany

15. Yves Lévy

    Institut de Recherche Vaccinale

    Affiliation as printed

    French Vaccine Research Institute (VRI), Paris, France

16. Wolfram Gottfried Metzger

    University of Tübingen

    Affiliation as printed

    Institute of Tropical Medicine, University of Tübingen, Germany

17. Volker Oeppling

    Paul Ehrlich Institut

    Affiliation as printed

    Paul-Ehrlich-Institut (PEI), Langen, Germany

18. Scott Stibitz

    United States Food and Drug Administration

    Affiliation as printed

    Food & Drug Administration (FDA), United States

19. Kawsar R. Talaat

    Johns Hopkins University

    Affiliation as printed

    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

20. Stephen James Thomas

    SUNY Upstate Medical University

    Affiliation as printed

    Division of Infectious Diseases, SUNY Upstate Medical University, United States Barry Walker, Biologics and Vaccine Development Consultant, United Kingdom

21. Adrian Wildfire
22. Beno Nyam Yakubu